Clinical • Tumor mutational burden
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • TMB (Tumor Mutational Burden) • FGFR2 (Fibroblast growth factor receptor 2) • IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • ARID1A (AT-rich interaction domain 1A) • TERT (Telomerase Reverse Transcriptase) • BAP1 (BRCA1 Associated Protein 1) • SMAD4 (SMAD family member 4) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • ARID2 (AT-Rich Interaction Domain 2) • GATA6 (GATA Binding Protein 6) • CDX2 (Caudal Type Homeobox 2) • KRT19 (Keratin 19) • SATB2 (SATB Homeobox 2)
|
TP53 mutation • PIK3CA mutation • ARID1A mutation • TMB-L • TERT mutation • CDX-2 expression